NaDeNo
Oslo, NO · 2 known investors
Find your way into NaDeNo
36 people in our graph share verified history with the NaDeNo team — schools, employers, funds. One of them is your warm intro.
Markus Dietrichunlockedknows Yrr Mørch · together at NTNU (overlapped)
×11knows the team · via NTNU
NaDeNo develops nanoparticle drug delivery technology that encapsulates hard-to-deliver molecules through a proprietary one-step process without chemical modification. The platform serves pharmaceutical companies and biotech partners seeking to improve formulation of poorly soluble or hydrophobic therapeutics.
Founders & leadership
YM
Yrr MørchCo-founder & Chief Technology OfficerCo-founder and CTO of NaDeNo, which develops nanoparticle drug delivery technology for encapsulating hard-to-deliver molecules. Mørch's expertise spans nanomedicine, biopolymer chemistry, nanoparticle characterization, and related areas such as controlled release, microfluidics, and imaging contrast agents.
Investors · 2
In the news
Frequently asked questions
- What does NaDeNo do?
- NaDeNo develops nanoparticle drug delivery technology that encapsulates hard-to-deliver molecules through a proprietary one-step process without chemical modification. The platform serves pharmaceutical companies and biotech partners seeking to improve formulation of poorly soluble or hydrophobic therapeutics.
- Who founded NaDeNo?
- NaDeNo was founded by Annbjørg Falck, Yrr Mørch.
- Who are NaDeNo's investors?
- NaDeNo's investors include Farvatn Venture, Sondo Capital.
- Where is NaDeNo headquartered?
- NaDeNo is headquartered in Oslo, NO.